1. Home
  2. SQNS vs CTMX Comparison

SQNS vs CTMX Comparison

Compare SQNS & CTMX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SQNS
  • CTMX
  • Stock Information
  • Founded
  • SQNS 2003
  • CTMX 2008
  • Country
  • SQNS France
  • CTMX United States
  • Employees
  • SQNS N/A
  • CTMX N/A
  • Industry
  • SQNS Semiconductors
  • CTMX Biotechnology: Pharmaceutical Preparations
  • Sector
  • SQNS Technology
  • CTMX Health Care
  • Exchange
  • SQNS Nasdaq
  • CTMX Nasdaq
  • Market Cap
  • SQNS 147.0M
  • CTMX 349.6M
  • IPO Year
  • SQNS 2011
  • CTMX 2015
  • Fundamental
  • Price
  • SQNS $9.52
  • CTMX $1.93
  • Analyst Decision
  • SQNS Buy
  • CTMX Strong Buy
  • Analyst Count
  • SQNS 1
  • CTMX 4
  • Target Price
  • SQNS $3.50
  • CTMX $5.13
  • AVG Volume (30 Days)
  • SQNS 4.0M
  • CTMX 2.4M
  • Earning Date
  • SQNS 11-04-2025
  • CTMX 11-06-2025
  • Dividend Yield
  • SQNS N/A
  • CTMX N/A
  • EPS Growth
  • SQNS N/A
  • CTMX 263.20
  • EPS
  • SQNS 18.54
  • CTMX 0.49
  • Revenue
  • SQNS $37,325,000.00
  • CTMX $141,100,000.00
  • Revenue This Year
  • SQNS N/A
  • CTMX N/A
  • Revenue Next Year
  • SQNS $89.05
  • CTMX N/A
  • P/E Ratio
  • SQNS $0.52
  • CTMX $3.98
  • Revenue Growth
  • SQNS 32.07
  • CTMX 18.01
  • 52 Week Low
  • SQNS $0.73
  • CTMX $0.40
  • 52 Week High
  • SQNS $9.72
  • CTMX $3.10
  • Technical
  • Relative Strength Index (RSI)
  • SQNS 95.31
  • CTMX 41.17
  • Support Level
  • SQNS $0.93
  • CTMX $1.90
  • Resistance Level
  • SQNS $0.89
  • CTMX $2.16
  • Average True Range (ATR)
  • SQNS 0.10
  • CTMX 0.13
  • MACD
  • SQNS 0.60
  • CTMX -0.01
  • Stochastic Oscillator
  • SQNS 97.77
  • CTMX 7.50

About SQNS Sequans Communications S.A.

Sequans Communications SA is a designer, developer, and supplier of cellular semiconductor solutions for broadband Internet of Things (IoT) markets. Its offer 5G/4G chips and modules fully optimized for non-smartphone devices. The company covers applications such as smart mobility and logistics, smart utility meters, smart cities, smart industries, e-health and wellness, and smart homes to name few. The Company has one operating segment, which is the design and marketing of semiconductor components for cellular wireless systems. Its geographical segments are Taiwan, Korea, China (including Hong Kong), the Rest of Asia, the United States and the Rest of the world.

About CTMX CytomX Therapeutics Inc.

CytomX Therapeutics Inc a clinical-stage, oncology-focused biopharmaceutical company developing novel, masked, conditionally activated biologics designed to be localized to the tumor microenvironment. It is engaged in developing antibody therapeutics based on probody technology platforms. The company's probody technology platform creates proprietary cancer immunotherapies against clinically-validated targets and develops cancer therapeutics. Probody therapeutics are designed to take advantage of conditions in the tumor microenvironment to enhance the tumor-targeting features of an antibody and reduce drug activity in healthy tissues.

Share on Social Networks: